Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gut microbial modulation of 3-hydroxyanthranilic acid and dopaminergic signalling influences attention in obesity

  • Castells-Nobau, Anna
  • Samulenaite, Solveiga
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Mayneris Perxachs, Jordi
Background Obesity-related alterations in the gut microbiota have been linked to cognitive decline, yet their relationship with attention remains poorly understood. Objective To evaluate the possible relationships among gut metagenomics, plasma metabolomics and attention. Design We conducted faecal shotgun metagenomics and targeted plasma tryptophan metabolomics across three independent cohorts (n=156, n=124, n=804) with functional validations in preclinical models, including three faecal microbiota transplantation (FMT) experiments in mice and Drosophila melanogaster. Results Obesity was consistently associated with reduced attention. Metagenomics analyses identified Proteobacteria species and microbial functions related to tryptophan biosynthesis from anthranilic acid (AA) as negatively associated with attention in obesity. Plasma tryptophan metabolic profiling and machine learning revealed that 3-hydroxyanthranilic acid (3-HAA) was positively associated with attention, particularly in obesity, while AA showed a negative association. Bariatric surgery improved attention and enriched microbial species linked to attention. In mice, diet-induced obesity (DIO) and microbiota depletion reduced 3-HAA and 5-hydroxy-indole acetic acid (5-HIAA) concentrations in the prefrontal cortex (PFC), which were restored by FMT. Global metabolic profiling (>600 metabolites) of PFC from the FMT group identified 3-HAA and the tryptophan and tyrosine pathways among the most significant in mice receiving microbiota from high-attention donors. A second FMT experiment also revealed a consistent enrichment of the tryptophan and tyrosine metabolism at the transcriptional level in the PFC, with Haao (3-hydroxyantrhanilic acid dioxygenase) and Aox4 (aldehyde oxidase 4), key in 3-HAA and 5-HIAA degradation, among the significantly regulated genes. In a third FMT study, attentional traits were transmitted from humans to mice alongside modulation of serotonergic and dopaminergic pathways. In Drosophila, mono-colonisation with Enterobacter cloacae and DIO induced attention deficit-like behaviours, which were mitigated by 3-HAA supplementation. Conclusions We have identified the microbiota and 3-HAA as potential therapeutic targets to improve attention, especially in obesity., This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund. "A way to make Europe") to JM-P and PI21/01361 and PI24/00185 and ICREA-Acadèmia (#2021) to JMF-R, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCCADGUT to JM-P. AF is funded by the Horizon 2020 Framework Programme of the European Union under the Marie Sklodowska-Curie Innovative Training Network grant agreement No 859890. MA-R is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund "Investing in your future"). AC-N is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP24/00033 (co-funded by European Regional Development Fund "Investing in your future"). IDIBGI is a CERCA centre from the "CERCA Programme/Generalitat de Catalunya". This study was conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014-2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014-2020 and by the Diputació de Girona. We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This work was also supported by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI) (PID2020- 120029GB-I00/MICIN/AEI/ 10.13039/501100011033, RD21/0009/0019 and PDI20231511680B-C21), the Spanish "Instituto de Salud Carlos III, RETICSRTA" (#RD12/0028/0023), the "Generalitat de Catalunya, AGAUR" (#2017 SGR-669), "ICREA-Acadèmia" (#2015) and the Spanish "Ministerio de Sanidad, Servicios Sociales e Igualdad", "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD-2017I068) to RM, la Caixa Health" LCR/PR/HR22/5240017 to RM and EM-G, "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD2019I006, #PNSD-2023I040) and Spanish "Ministerio de Ciencia e Innovación" (ERA-NET) PCI2021-122073-2A to EM-G.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism

  • Fumagalli, Andrea
  • Castells-Nobau, Anna
  • Trivedi, Dakshat
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Ramió-Torrentà, Lluís
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Swann, Jonathan Richard
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
  • Mayneris Perxachs, Jordi
The relationship between bacteria, cognitive function and obesity is well established, yet the role of archaeal species remains underexplored. We used shotgun metagenomics and neuropsychological tests to identify microbial species associated with cognition in a discovery cohort (IRONMET, n = 125). Interestingly, methanogen archaeas exhibited the strongest positive associations with cognition, particularly Methanobrevibacter smithii (M. smithii). Stratifying individuals by median-centered log ratios (CLR) of M. smithii (low and high M. smithii groups: LMs and HMs) revealed that HMs exhibited better cognition and distinct gut bacterial profiles (PERMANOVA p = 0.001), characterized by increased levels of Verrucomicrobia, Synergistetes and Lentisphaerae species and reduced levels of Bacteroidetes and Proteobacteria. Several of these species were linked to the cognitive test scores. These findings were replicated in a large-scale validation cohort (Aging Imageomics, n = 942). Functional analyses revealed an enrichment of energy, butyrate, and bile acid metabolism in HMs in both cohorts. Global plasma metabolomics by CIL LC-MS in IRONMET identified an enrichment of methylhistidine, phenylacetate, alpha-linolenic and linoleic acid, and secondary bile acid metabolism associated with increased levels of 3-methylhistidine, phenylacetylgluamine, adrenic acid, and isolithocholic acid in the HMs group. Phenylacetate and linoleic acid metabolism also emerged in the Aging Imageomics cohort performing untargeted HPLC-ESI-MS/MS metabolic profiling, while a targeted bile acid profiling identified again isolithocholic acid as one of the most significant bile acid increased in the HMs. 3-Methylhistidine levels were also associated with intense physical activity in a second validation cohort (IRONMET-CGM, n = 116). Finally, FMT from HMs donors improved cognitive flexibility, reduced weight, and altered SCFAs, histidine-, linoleic acid- and phenylalanine-related metabolites in the dorsal striatum of recipient mice. M. smithii seems to interact with the bacterial ecosystem affecting butyrate, histidine, phenylalanine, and linoleic acid metabolism with a positive impact on cognition, constituting a promising therapeutic target to enhance cognitive performance, especially in subjects with obesity., (ISCIII, Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to J.M-P, and (2021 SGR 01263). This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCC-ADGUT to J.M.-P. J.M-P and A.C.N are funded by (Madrid, Spain) through the Miguel Servet Program CP18/00009 and CP24/00033 (co-funded by the European Union under the European Social Fund “Investing in your future”), respectively. A.F. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. This study was conducted using samples/data from the Aging Imageomics Study, supported by the through the Strategic Plan for Health Research and Innovation (PERIS) 2016–2020 (SLT002/16/00250). We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. JRS is supported by the NIHR Southampton Biomedical Research Centre, and the Biotechnology and Biological Sciences Research Council (BB/W00139X/1).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection

  • Castillo Izquierdo, Ángela del
  • Moreno Navarrete, José María
  • Latorre, Jèssica
  • Arnoriaga Rodríguez, María
  • Ballanti, Marta
  • Monteleone, Giovanni
  • Paoluzi, Alessandro Omero
  • Mingrone, Geltrude
  • Puig, Josep
  • Ramos, Rafael
  • Garre Olmo, Josep
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Sol, Joaquim
  • Lefevre, Philippe
  • Staels, Bart
  • Federici, Massimo
  • Fernández Real, José Manuel
  • Mayneris Perxachs, Jordi
Dipeptidyl peptidase 9 (DPP9) is a member of the dipeptidyl peptidase IV family. Inhibition of DPP9 has recently been shown to activate the nucleotide-binding domain leucine-rich repeat 1 (NLRP1) inflammasome. NLRP1 is known to bind nucleic acids with high affinity and directly interact with double stranded RNA, which plays a key role in viral replication. DPP9 has also recently emerged as a key gene related to lung-inflammation in critical SARS-CoV-2 infection. Importantly, DPP9 activity is strongly dependent on the oxidative status. Here, we explored the potential role of DPP9 in the gastrointestinal tract. We performed transcriptomics analyses of colon (microarray, n = 37) and jejunal (RNA sequencing, n = 31) biopsies from two independent cohorts as well as plasma metabolomics analyses in two independent cohorts (n = 37 and n = 795). The expression of DPP9 in the jejunum, colon, and blood was significantly associated with circulating biomarkers of oxidative stress (uric acid, bilirubin). It was also associated positively with the expression of transcription factors (NRF-2) and genes (SOD, CAT, GPX) encoding for antioxidant enzymes, but negatively with that of genes (XDH, NOX) and transcription factors (NF-KB) involved in ROS-generating enzymes. Gene co-expression patterns associated with DPP9 identified several genes participating in antiviral pathways in both tissues. Notably, DPP9 expression in the colon and plasma was strongly positively associated with several circulating nucleotide catabolites (hypoxanthine, uric acid, 3-ureidopropionic acid) with important roles in the generation of ROS and viral infection, as well as other metabolites related to oxidative stress (Resolvin D1, glutamate-containing dipeptides). Gene-drug enrichment analyses identified artenimol, puromycin, anisomycin, 3-phenyllactic acid, and linezolid as the most promising drugs targeting these DPP9-associated genes. We have identified a novel potential pathogenic mechanism of viral infection in the digestive tract and promising existing drugs that can be repositioned against viral infection., This work was partially supported by Fundació Marató de TV3 research grant number 201612-31 and by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the project PI20/01090 (co-funded by the European Union under the European Regional Development Fund (FEDER). “A way to make Europe”) to J.M.-P. Á.d.C.-I. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. M.A.-R. is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund “Investing in your future”). J.M.-P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Regional Development Fund “Investing in your future”).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men

  • Rosell Díaz, Marisel
  • Petit Gay, Anna
  • Molas Prat, Clàudia
  • Gallardo Nuell, Laura
  • Ramió Torrentà, Lluís
  • Garre Olmo, Josep
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Bäckhed, Fredrik
  • Mayneris Perxachs, Jordi
  • Fernández Real, José Manuel
Background : An altered gut microbiome characterized by reduced abundance of butyrate producing bacteria and reduced gene richness is associated with type 2 diabetes (T2D). An important complication of T2D is increased risk of cognitive impairment and dementia. The biguanide metformin is a commonly prescribed medication for the control of T2D and metformin treatment has been associated with a significant reduction in the risk of dementia and improved cognition, particularly in people with T2D. Aim : To investigate the associations of metformin use with cognition exploring potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively. Methods : We explored two independent cohorts: an observational study (Aging Imageomics) and a phase IV, randomized, double-blind, parallel-group, randomized pilot study (MEIFLO). From the two studies, we analyzed four study groups: (1) individuals with no documented medical history or medical treatment (n = 172); (2) people with long-term T2D on metformin monotherapy (n = 134); (3) people with long-term T2D treated with oral hypoglycemic agents other than metformin (n = 45); (4) a newly diagnosed T2D subjects on metformin monotherapy (n = 22). Analyses were also performed stratifying by sex. Results : Several bacterial species belonging to the Proteobacteria (Escherichia coli) and Verrucomicrobia (Akkermansia muciniphila) phyla were positively associated with metformin treatment, while bacterial species belonging to the Firmicutes phylum (Romboutsia timonensis, Romboutsia ilealis) were negatively associated. Due to the consistent increase in A. muciniphila and decrease in R.ilealis in people with T2D subjects treated with metformin, we investigated the association between this ratio and cognition. In the entire cohort of metformin-treated T2D subjects, the A.muciniphila/R.ilealis ratio was not significantly associated with cognitive test scores. However, after stratifying by sex, the A.muciniphila/R. ilealis ratio was significantly and positively associated with higher memory scores and improved memory in men. Metformin treatment was associated with an enrichment of microbial pathways involved in the TCA cycle, and butanoate, arginine, and proline metabolism in both cohorts. The bacterial genes involved in arginine metabolism, especially in production of glutamate (astA, astB, astC, astD, astE, putA), were enriched following metformin intake. In agreement, in the metabolomics analysis, metformin treatment was strongly associated with the amino acid proline, a metabolite involved in the metabolism of glutamate. Conclusions : The beneficial effects of metformin may be mediated by changes in the composition of the gut microbiota and microbial-host-derived co-metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934 and PI21/ 01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska- Curie Innovative Training Network grant agreement No 859890. Open Access funding provided by the CRUE-CSIC agreement with Elsevier. The Aging Imageomics Study has been funded by Pla estrat`egic de recerca i innovaci´o en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/00250). IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. is a ‘Serra-Hunter’ Fellow. J.M.- P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Union under the European Social Fund “Investing in your future”). J.M.-P. was also supported through the project CNS2023-144218 funded by MICIU/ AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Gut microbiota links to serum ferritin and cognition

  • Rosell Díaz, Marisel
  • Santos González, Elena
  • Motger Albertí, Anna
  • Ramió Torrentà, Lluís
  • Garre Olmo, Josep
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Fernández Real, José Manuel
  • Mayneris Perxachs, Jordi
Iron is required for the replication and growth of almost all bacterial species and in the production of myelin and neurotransmitters. Increasing clinical studies evidence that the gut microbiota plays a critical role in iron metabolism and cognition. However, the understanding of the complex iron-microbiome-cognition crosstalk remains elusive. In a recent study in the Aging Imageomics cohort (n = 1,030), we identified a positive association of serum ferritin (SF) with executive function (EF) as inferred from the semantic verbal fluency (SVF,) the total digit span (TDS) and the phonemic verbal fluency tests (PVF). Here, we explored the potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively. Different bacterial species belonging to the Proteobacteria phylum (Klebsiella pneumoniae, Klebsiella michiganensis, Unclassified Escherichia) were negatively associated both with SF and executive function. At the functional level, an enrichment of microbial pathways involved in phenylalanine, arginine, and proline metabolism was identified. Consistently, phenylacetylglutamine, a metabolite derived from microbial catabolism of phenylalanine, was negatively associated with SF, EF, and semantic memory. Other metabolites such as ureidobutyric acid and 19,20-DiHDPA, a DHA-derived oxylipin, were also consistently and negatively associated with SF, EF, and semantic memory, while plasma eicosapentaenoic acid was positively associated. The associations of SF with cognition could be mediated by the gut microbiome through microbial-derived metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the project PI15/01934 and PI21/01361 to J.M.F-R and the project PI20/01090 (co-funded by the European Union under the European Regional Development Fund (FEDER). “A way to make Europe”) to J. M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. The Aging Imageomics Study has been funded by Pla estratègic de recerca i innovació en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/ 00250). The Health Imageomics has been funded by Health LivingLab operation of the Girona Healthy Region Program which was granted by the Projectes d’Especialització i Competitivitat Territorial (PECT) of the RIS3Cat and the Operative Programme of the European Regional Development Fund of Catalonia 2014-2020. Albert Einstein College of Medicine owns the copyright for the Memory Binding Test and makes it available as a service to the research community but charges for commercial use (for permission requests contact the AECOM at: biotech@einstein.yu.edu); the Spanish and Catalan adaptations used were provided by the BarcelonaBeta Brain Research Center and the Pasqual Maragall Foundation with the AECOM’s permission. For further information about these versions, contact Nina Gramunt at: ngramunt@pmaragall.org. IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. and J. G. are ‘Serra-Hunter’ Fellows. J.M.-P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Regional Development Fund “Investing in your future”).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota links to serum ferritin and cognition

  • Rosell-Díaz, Marisel
  • Santos-González, Elena
  • Motger-Albertí, Anna
  • Ramió-Torrentà, Lluís
  • Garre-Olmo, Josep
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Jové, Mariona
  • Pamplona, Reinald
  • Puig, Josep
  • Ramos, Rafel
  • Fernández-Real, José Manuel
  • Mayneris-Perxachs, Jordi
Iron is required for the replication and growth of almost all bacterial species and in the production of myelin and neurotransmitters. Increasing clinical studies evidence that the gut microbiota plays a critical role in iron metabolism and cognition. However, the understanding of the complex iron-microbiome-cognition crosstalk remains elusive. In a recent study in the Aging Imageomics cohort (n = 1,030), we identified a positive association of serum ferritin (SF) with executive function (EF) as inferred from the semantic verbal fluency (SVF,) the total digit span (TDS) and the phonemic verbal fluency tests (PVF). Here, we explored the potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively. Different bacterial species belonging to the Proteobacteria phylum (Klebsiella pneumoniae, Klebsiella michiganensis, Unclassified Escherichia) were negatively associated both with SF and executive function. At the functional level, an enrichment of microbial pathways involved in phenylalanine, arginine, and proline metabolism was identified. Consistently, phenylacetylglutamine, a metabolite derived from microbial catabolism of phenylalanine, was negatively associated with SF, EF, and semantic memory. Other metabolites such as ureidobutyric acid and 19,20-DiHDPA, a DHA-derived oxylipin, were also consistently and negatively associated with SF, EF, and semantic memory, while plasma eicosapentaenoic acid was positively associated. The associations of SF with cognition could be mediated by the gut microbiome through microbial-derived metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the project PI15/01934 and PI21/01361 to J.M.F-R and the project PI20/01090 (co-funded by the European Union under the European Regional Development Fund (FEDER). “A way to make Europe”) to J. M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. The Aging Imageomics Study has been funded by Pla estratègic de recerca i innovació en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/ 00250). The Health Imageomics has been funded by Health LivingLab operation of the Girona Healthy Region Program which was granted by the Projectes d’Especialització i Competitivitat Territorial (PECT) of the RIS3Cat and the Operative Programme of the European Regional Development Fund of Catalonia 2014-2020. Albert Einstein College of Medicine owns the copyright for the Memory Binding Test and makes it available as a service to the research community but charges for commercial use (for permission requests contact the AECOM at: biotech@einstein.yu.edu); the Spanish and Catalan adaptations used were provided by the BarcelonaBeta Brain Research Center and the Pasqual Maragall Foundation with the AECOM’s permission. For further information about these versions, contact Nina Gramunt at: ngramunt@pmaragall.org. IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. and J. G. are ‘Serra-Hunter’ Fellows. J.M.-P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Regional Development Fund “Investing in your future”)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men

  • Rosell-Díaz, Marisel
  • Petit-Gay, Anna
  • Molas-Prat, Clàudia
  • Gallardo-Nuell, Laura
  • Ramió-Torrentà, Lluís
  • Garre-Olmo, Josep
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Jové, Mariona
  • Pamplona, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Bäckhed, Fredrik
  • Mayneris-Perxachs, Jordi
  • Fernández-Real, José Manuel
[Background]: An altered gut microbiome characterized by reduced abundance of butyrate producing bacteria and reduced gene richness is associated with type 2 diabetes (T2D). An important complication of T2D is increased risk of cognitive impairment and dementia. The biguanide metformin is a commonly prescribed medication for the control of T2D and metformin treatment has been associated with a significant reduction in the risk of dementia and improved cognition, particularly in people with T2D., [Aim]: To investigate the associations of metformin use with cognition exploring potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively., [Methods]: We explored two independent cohorts: an observational study (Aging Imageomics) and a phase IV, randomized, double-blind, parallel-group, randomized pilot study (MEIFLO). From the two studies, we analyzed four study groups: (1) individuals with no documented medical history or medical treatment (n = 172); (2) people with long-term T2D on metformin monotherapy (n = 134); (3) people with long-term T2D treated with oral hypoglycemic agents other than metformin (n = 45); (4) a newly diagnosed T2D subjects on metformin monotherapy (n = 22). Analyses were also performed stratifying by sex., [Results]: Several bacterial species belonging to the Proteobacteria (Escherichia coli) and Verrucomicrobia (Akkermansia muciniphila) phyla were positively associated with metformin treatment, while bacterial species belonging to the Firmicutes phylum (Romboutsia timonensis, Romboutsia ilealis) were negatively associated. Due to the consistent increase in A. muciniphila and decrease in R.ilealis in people with T2D subjects treated with metformin, we investigated the association between this ratio and cognition. In the entire cohort of metformin-treated T2D subjects, the A.muciniphila/R.ilealis ratio was not significantly associated with cognitive test scores. However, after stratifying by sex, the A.muciniphila/R. ilealis ratio was significantly and positively associated with higher memory scores and improved memory in men. Metformin treatment was associated with an enrichment of microbial pathways involved in the TCA cycle, and butanoate, arginine, and proline metabolism in both cohorts. The bacterial genes involved in arginine metabolism, especially in production of glutamate (astA, astB, astC, astD, astE, putA), were enriched following metformin intake. In agreement, in the metabolomics analysis, metformin treatment was strongly associated with the amino acid proline, a metabolite involved in the metabolism of glutamate., [Conclusions]: The beneficial effects of metformin may be mediated by changes in the composition of the gut microbiota and microbial-host-derived co-metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934 and PI21/01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. The Aging Imageomics Study has been funded by Pla estratègic de recerca i innovació en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/00250). IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. is a ‘Serra-Hunter’ Fellow. J.M.-P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Union under the European Social Fund “Investing in your future”). J.M.-P. was also supported through the project CNS2023-144218 funded by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR., Open Access funding provided by the CRUE-CSIC agreement with Elsevier., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism

  • Fumagalli, Andrea
  • Castells-Nobau, Anna
  • Trivedi, Dakshat
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Swann, Jonathan
  • Martin-Garcia, Elena
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
The relationship between bacteria, cognitive function and obesity is well established, yet the role of archaeal species remains underexplored. We used shotgun metagenomics and neuropsychological tests to identify microbial species associated with cognition in a discovery cohort (IRONMET, n = 125). Interestingly, methanogen archaeas exhibited the strongest positive associations with cognition, particularly Methanobrevibacter smithii (M. smithii). Stratifying individuals by median-centered log ratios (CLR) of M. smithii (low and high M. smithii groups: LMs and HMs) revealed that HMs exhibited better cognition and distinct gut bacterial profiles (PERMANOVA p = 0.001), characterized by increased levels of Verrucomicrobia, Synergistetes and Lentisphaerae species and reduced levels of Bacteroidetes and Proteobacteria. Several of these species were linked to the cognitive test scores. These findings were replicated in a large-scale validation cohort (Aging Imageomics, n = 942). Functional analyses revealed an enrichment of energy, butyrate, and bile acid metabolism in HMs in both cohorts. Global plasma metabolomics by CIL LC-MS in IRONMET identified an enrichment of methylhistidine, phenylacetate, alpha-linolenic and linoleic acid, and secondary bile acid metabolism associated with increased levels of 3-methylhistidine, phenylacetylgluamine, adrenic acid, and isolithocholic acid in the HMs group. Phenylacetate and linoleic acid metabolism also emerged in the Aging Imageomics cohort performing untargeted HPLC-ESI-MS/MS metabolic profiling, while a targeted bile acid profiling identified again isolithocholic acid as one of the most significant bile acid increased in the HMs. 3-Methylhistidine levels were also associated with intense physical activity in a second validation cohort (IRONMET-CGM, n = 116). Finally, FMT from HMs donors improved cognitive flexibility, reduced weight, and altered SCFAs, histidine-, linoleic acid- and phenylalanine-related metabolites in the dorsal striatum of recipient mice. M. smithii seems to interact with the bacterial ecosystem affecting butyrate, histidine, phenylalanine, and linoleic acid metabolism with a positive impact on cognition, constituting a promising therapeutic target to enhance cognitive performance, especially in subjects with obesity., (ISCIII, Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to J.M-P, and (2021 SGR 01263). This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCC-ADGUT to J.M.-P. J.M-P and A.C.N are funded by (Madrid, Spain) through the Miguel Servet Program CP18/00009 and CP24/00033 (co-funded by the European Union under the European Social Fund “Investing in your future”), respectively. A.F. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. This study was conducted using samples/data from the Aging Imageomics Study, supported by the through the Strategic Plan for Health Research and Innovation (PERIS) 2016–2020 (SLT002/16/00250). We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. JRS is supported by the NIHR Southampton Biomedical Research Centre, and the Biotechnology and Biological Sciences Research Council (BB/W00139X/1)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbial modulation of 3-hydroxyanthranilic acid and dopaminergic signalling influences attention in obesity

  • Castells-Nobau, Anna
  • Samulenaite, Solveiga
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Mayneris Perxachs, Jordi
Background Obesity-related alterations in the gut microbiota have been linked to cognitive decline, yet their relationship with attention remains poorly understood. Objective To evaluate the possible relationships among gut metagenomics, plasma metabolomics and attention. Design We conducted faecal shotgun metagenomics and targeted plasma tryptophan metabolomics across three independent cohorts (n=156, n=124, n=804) with functional validations in preclinical models, including three faecal microbiota transplantation (FMT) experiments in mice and Drosophila melanogaster. Results Obesity was consistently associated with reduced attention. Metagenomics analyses identified Proteobacteria species and microbial functions related to tryptophan biosynthesis from anthranilic acid (AA) as negatively associated with attention in obesity. Plasma tryptophan metabolic profiling and machine learning revealed that 3-hydroxyanthranilic acid (3-HAA) was positively associated with attention, particularly in obesity, while AA showed a negative association. Bariatric surgery improved attention and enriched microbial species linked to attention. In mice, diet-induced obesity (DIO) and microbiota depletion reduced 3-HAA and 5-hydroxy-indole acetic acid (5-HIAA) concentrations in the prefrontal cortex (PFC), which were restored by FMT. Global metabolic profiling (>600 metabolites) of PFC from the FMT group identified 3-HAA and the tryptophan and tyrosine pathways among the most significant in mice receiving microbiota from high-attention donors. A second FMT experiment also revealed a consistent enrichment of the tryptophan and tyrosine metabolism at the transcriptional level in the PFC, with Haao (3-hydroxyantrhanilic acid dioxygenase) and Aox4 (aldehyde oxidase 4), key in 3-HAA and 5-HIAA degradation, among the significantly regulated genes. In a third FMT study, attentional traits were transmitted from humans to mice alongside modulation of serotonergic and dopaminergic pathways. In Drosophila, mono-colonisation with Enterobacter cloacae and DIO induced attention deficit-like behaviours, which were mitigated by 3-HAA supplementation. Conclusions We have identified the microbiota and 3-HAA as potential therapeutic targets to improve attention, especially in obesity., This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund. "A way to make Europe") to JM-P and PI21/01361 and PI24/00185 and ICREA-Acadèmia (#2021) to JMF-R, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCCADGUT to JM-P. AF is funded by the Horizon 2020 Framework Programme of the European Union under the Marie Sklodowska-Curie Innovative Training Network grant agreement No 859890. MA-R is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund "Investing in your future"). AC-N is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP24/00033 (co-funded by European Regional Development Fund "Investing in your future"). IDIBGI is a CERCA centre from the "CERCA Programme/Generalitat de Catalunya". This study was conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014-2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014-2020 and by the Diputació de Girona. We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This work was also supported by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI) (PID2020- 120029GB-I00/MICIN/AEI/ 10.13039/501100011033, RD21/0009/0019 and PDI20231511680B-C21), the Spanish "Instituto de Salud Carlos III, RETICSRTA" (#RD12/0028/0023), the "Generalitat de Catalunya, AGAUR" (#2017 SGR-669), "ICREA-Acadèmia" (#2015) and the Spanish "Ministerio de Sanidad, Servicios Sociales e Igualdad", "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD-2017I068) to RM, la Caixa Health" LCR/PR/HR22/5240017 to RM and EM-G, "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD2019I006, #PNSD-2023I040) and Spanish "Ministerio de Ciencia e Innovación" (ERA-NET) PCI2021-122073-2A to EM-G.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism

  • Fumagalli, Andrea
  • Castells-Nobau, Anna
  • Trivedi, Dakshat
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Ramió-Torrentà, Lluís
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Swann, Jonathan Richard
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
  • Mayneris Perxachs, Jordi
The relationship between bacteria, cognitive function and obesity is well established, yet the role of archaeal species remains underexplored. We used shotgun metagenomics and neuropsychological tests to identify microbial species associated with cognition in a discovery cohort (IRONMET, n = 125). Interestingly, methanogen archaeas exhibited the strongest positive associations with cognition, particularly Methanobrevibacter smithii (M. smithii). Stratifying individuals by median-centered log ratios (CLR) of M. smithii (low and high M. smithii groups: LMs and HMs) revealed that HMs exhibited better cognition and distinct gut bacterial profiles (PERMANOVA p = 0.001), characterized by increased levels of Verrucomicrobia, Synergistetes and Lentisphaerae species and reduced levels of Bacteroidetes and Proteobacteria. Several of these species were linked to the cognitive test scores. These findings were replicated in a large-scale validation cohort (Aging Imageomics, n = 942). Functional analyses revealed an enrichment of energy, butyrate, and bile acid metabolism in HMs in both cohorts. Global plasma metabolomics by CIL LC-MS in IRONMET identified an enrichment of methylhistidine, phenylacetate, alpha-linolenic and linoleic acid, and secondary bile acid metabolism associated with increased levels of 3-methylhistidine, phenylacetylgluamine, adrenic acid, and isolithocholic acid in the HMs group. Phenylacetate and linoleic acid metabolism also emerged in the Aging Imageomics cohort performing untargeted HPLC-ESI-MS/MS metabolic profiling, while a targeted bile acid profiling identified again isolithocholic acid as one of the most significant bile acid increased in the HMs. 3-Methylhistidine levels were also associated with intense physical activity in a second validation cohort (IRONMET-CGM, n = 116). Finally, FMT from HMs donors improved cognitive flexibility, reduced weight, and altered SCFAs, histidine-, linoleic acid- and phenylalanine-related metabolites in the dorsal striatum of recipient mice. M. smithii seems to interact with the bacterial ecosystem affecting butyrate, histidine, phenylalanine, and linoleic acid metabolism with a positive impact on cognition, constituting a promising therapeutic target to enhance cognitive performance, especially in subjects with obesity., (ISCIII, Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to J.M-P, and (2021 SGR 01263). This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCC-ADGUT to J.M.-P. J.M-P and A.C.N are funded by (Madrid, Spain) through the Miguel Servet Program CP18/00009 and CP24/00033 (co-funded by the European Union under the European Social Fund “Investing in your future”), respectively. A.F. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. This study was conducted using samples/data from the Aging Imageomics Study, supported by the through the Strategic Plan for Health Research and Innovation (PERIS) 2016–2020 (SLT002/16/00250). We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. JRS is supported by the NIHR Southampton Biomedical Research Centre, and the Biotechnology and Biological Sciences Research Council (BB/W00139X/1).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection

  • Castillo Izquierdo, Ángela del
  • Moreno Navarrete, José María
  • Latorre, Jèssica
  • Arnoriaga Rodríguez, María
  • Ballanti, Marta
  • Monteleone, Giovanni
  • Paoluzi, Alessandro Omero
  • Mingrone, Geltrude
  • Puig, Josep
  • Ramos, Rafael
  • Garre Olmo, Josep
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Sol, Joaquim
  • Lefevre, Philippe
  • Staels, Bart
  • Federici, Massimo
  • Fernández Real, José Manuel
  • Mayneris Perxachs, Jordi
Dipeptidyl peptidase 9 (DPP9) is a member of the dipeptidyl peptidase IV family. Inhibition of DPP9 has recently been shown to activate the nucleotide-binding domain leucine-rich repeat 1 (NLRP1) inflammasome. NLRP1 is known to bind nucleic acids with high affinity and directly interact with double stranded RNA, which plays a key role in viral replication. DPP9 has also recently emerged as a key gene related to lung-inflammation in critical SARS-CoV-2 infection. Importantly, DPP9 activity is strongly dependent on the oxidative status. Here, we explored the potential role of DPP9 in the gastrointestinal tract. We performed transcriptomics analyses of colon (microarray, n = 37) and jejunal (RNA sequencing, n = 31) biopsies from two independent cohorts as well as plasma metabolomics analyses in two independent cohorts (n = 37 and n = 795). The expression of DPP9 in the jejunum, colon, and blood was significantly associated with circulating biomarkers of oxidative stress (uric acid, bilirubin). It was also associated positively with the expression of transcription factors (NRF-2) and genes (SOD, CAT, GPX) encoding for antioxidant enzymes, but negatively with that of genes (XDH, NOX) and transcription factors (NF-KB) involved in ROS-generating enzymes. Gene co-expression patterns associated with DPP9 identified several genes participating in antiviral pathways in both tissues. Notably, DPP9 expression in the colon and plasma was strongly positively associated with several circulating nucleotide catabolites (hypoxanthine, uric acid, 3-ureidopropionic acid) with important roles in the generation of ROS and viral infection, as well as other metabolites related to oxidative stress (Resolvin D1, glutamate-containing dipeptides). Gene-drug enrichment analyses identified artenimol, puromycin, anisomycin, 3-phenyllactic acid, and linezolid as the most promising drugs targeting these DPP9-associated genes. We have identified a novel potential pathogenic mechanism of viral infection in the digestive tract and promising existing drugs that can be repositioned against viral infection., This work was partially supported by Fundació Marató de TV3 research grant number 201612-31 and by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the project PI20/01090 (co-funded by the European Union under the European Regional Development Fund (FEDER). “A way to make Europe”) to J.M.-P. Á.d.C.-I. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. M.A.-R. is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund “Investing in your future”). J.M.-P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Regional Development Fund “Investing in your future”).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men

  • Rosell Díaz, Marisel
  • Petit Gay, Anna
  • Molas Prat, Clàudia
  • Gallardo Nuell, Laura
  • Ramió Torrentà, Lluís
  • Garre Olmo, Josep
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Bäckhed, Fredrik
  • Mayneris Perxachs, Jordi
  • Fernández Real, José Manuel
Background : An altered gut microbiome characterized by reduced abundance of butyrate producing bacteria and reduced gene richness is associated with type 2 diabetes (T2D). An important complication of T2D is increased risk of cognitive impairment and dementia. The biguanide metformin is a commonly prescribed medication for the control of T2D and metformin treatment has been associated with a significant reduction in the risk of dementia and improved cognition, particularly in people with T2D. Aim : To investigate the associations of metformin use with cognition exploring potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively. Methods : We explored two independent cohorts: an observational study (Aging Imageomics) and a phase IV, randomized, double-blind, parallel-group, randomized pilot study (MEIFLO). From the two studies, we analyzed four study groups: (1) individuals with no documented medical history or medical treatment (n = 172); (2) people with long-term T2D on metformin monotherapy (n = 134); (3) people with long-term T2D treated with oral hypoglycemic agents other than metformin (n = 45); (4) a newly diagnosed T2D subjects on metformin monotherapy (n = 22). Analyses were also performed stratifying by sex. Results : Several bacterial species belonging to the Proteobacteria (Escherichia coli) and Verrucomicrobia (Akkermansia muciniphila) phyla were positively associated with metformin treatment, while bacterial species belonging to the Firmicutes phylum (Romboutsia timonensis, Romboutsia ilealis) were negatively associated. Due to the consistent increase in A. muciniphila and decrease in R.ilealis in people with T2D subjects treated with metformin, we investigated the association between this ratio and cognition. In the entire cohort of metformin-treated T2D subjects, the A.muciniphila/R.ilealis ratio was not significantly associated with cognitive test scores. However, after stratifying by sex, the A.muciniphila/R. ilealis ratio was significantly and positively associated with higher memory scores and improved memory in men. Metformin treatment was associated with an enrichment of microbial pathways involved in the TCA cycle, and butanoate, arginine, and proline metabolism in both cohorts. The bacterial genes involved in arginine metabolism, especially in production of glutamate (astA, astB, astC, astD, astE, putA), were enriched following metformin intake. In agreement, in the metabolomics analysis, metformin treatment was strongly associated with the amino acid proline, a metabolite involved in the metabolism of glutamate. Conclusions : The beneficial effects of metformin may be mediated by changes in the composition of the gut microbiota and microbial-host-derived co-metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934 and PI21/ 01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska- Curie Innovative Training Network grant agreement No 859890. Open Access funding provided by the CRUE-CSIC agreement with Elsevier. The Aging Imageomics Study has been funded by Pla estrat`egic de recerca i innovaci´o en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/00250). IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. is a ‘Serra-Hunter’ Fellow. J.M.- P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Union under the European Social Fund “Investing in your future”). J.M.-P. was also supported through the project CNS2023-144218 funded by MICIU/ AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbiota links to serum ferritin and cognition

  • Rosell Díaz, Marisel
  • Santos González, Elena
  • Motger Albertí, Anna
  • Ramió Torrentà, Lluís
  • Garre Olmo, Josep
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Fernández Real, José Manuel
  • Mayneris Perxachs, Jordi
Iron is required for the replication and growth of almost all bacterial species and in the production of myelin and neurotransmitters. Increasing clinical studies evidence that the gut microbiota plays a critical role in iron metabolism and cognition. However, the understanding of the complex iron-microbiome-cognition crosstalk remains elusive. In a recent study in the Aging Imageomics cohort (n = 1,030), we identified a positive association of serum ferritin (SF) with executive function (EF) as inferred from the semantic verbal fluency (SVF,) the total digit span (TDS) and the phonemic verbal fluency tests (PVF). Here, we explored the potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively. Different bacterial species belonging to the Proteobacteria phylum (Klebsiella pneumoniae, Klebsiella michiganensis, Unclassified Escherichia) were negatively associated both with SF and executive function. At the functional level, an enrichment of microbial pathways involved in phenylalanine, arginine, and proline metabolism was identified. Consistently, phenylacetylglutamine, a metabolite derived from microbial catabolism of phenylalanine, was negatively associated with SF, EF, and semantic memory. Other metabolites such as ureidobutyric acid and 19,20-DiHDPA, a DHA-derived oxylipin, were also consistently and negatively associated with SF, EF, and semantic memory, while plasma eicosapentaenoic acid was positively associated. The associations of SF with cognition could be mediated by the gut microbiome through microbial-derived metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the project PI15/01934 and PI21/01361 to J.M.F-R and the project PI20/01090 (co-funded by the European Union under the European Regional Development Fund (FEDER). “A way to make Europe”) to J. M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. The Aging Imageomics Study has been funded by Pla estratègic de recerca i innovació en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/ 00250). The Health Imageomics has been funded by Health LivingLab operation of the Girona Healthy Region Program which was granted by the Projectes d’Especialització i Competitivitat Territorial (PECT) of the RIS3Cat and the Operative Programme of the European Regional Development Fund of Catalonia 2014-2020. Albert Einstein College of Medicine owns the copyright for the Memory Binding Test and makes it available as a service to the research community but charges for commercial use (for permission requests contact the AECOM at: biotech@einstein.yu.edu); the Spanish and Catalan adaptations used were provided by the BarcelonaBeta Brain Research Center and the Pasqual Maragall Foundation with the AECOM’s permission. For further information about these versions, contact Nina Gramunt at: ngramunt@pmaragall.org. IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. and J. G. are ‘Serra-Hunter’ Fellows. J.M.-P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Regional Development Fund “Investing in your future”).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lower serum ferritin levels are associated with worse cognitive performance in aging

  • Rosell-Díaz, Marisel|||0000-0001-7599-6584
  • Santos-González, Elena
  • Motger Albertí, Anna|||0000-0002-9430-371X
  • Gallardo-Nuell, Laura
  • Arnoriaga-Rodriguez, Maria|||0000-0002-0394-1223
  • Coll-Martínez, Clàudia|||0000-0003-2927-4008
  • Ramió-Torrentà, Lluís|||0000-0002-6999-1004
  • Garre-Olmo, Josep|||0000-0002-7817-0814
  • Puig, Josep|||0000-0003-2791-6599
  • Ramos, Rafel|||0000-0001-7970-5537
  • Mayneris-Perxachs, Jordi|||0000-0003-3788-3815
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
Objectives: Iron is important for neurogenesis, synaptic development, and neurotransmitter synthesis. Serum ferritin (SF) is a reliable marker for assessing iron stores. Therefore, we evaluated the cognitive function associated with SF levels. We also assessed brain iron content using R2* Magnetic Resonance Imaging (MRI) and its association with SF levels. Design: Data from three cross-sectional observational studies were used. Aging Imageomics (n = 1030) was conducted on aged subjects. Health Imageomics (n = 971) and IR0NMET (n = 175) were conducted in middle-aged subjects. Setting and participants: Participants were enrolled at Dr. Josep Trueta University Hospital facilities. The three cohorts included a total of 2176 subjects (mean age, 52 years; 48% men). Measurements: SF levels were measured by standard laboratory methods. Total Digits Span (TDS), and Phonemic Verbal Fluency (PVF) were used to assess executive function. Language function was assessed by semantic verbal fluency (SVF), attention by the Symbol Digit Modalities Test, and memory by the Memory Binding Tests - Total Free Recall and Total Delayed Free Recall. MRI was used to assess the iron content of the brain by R2*. Results: In subjects aged 65 years or older, SF levels were associated with increased TDS (β = 0.003, p = 0.02), PVF (β = 0.004, p = 0.01), and SVF (β = 0.004, p = 0.002) scores. After stratification by sex, these findings were significant only in men, where SF was associated with increased TDS (β = 0.003, p = 0.01), PVF (β = 0.004, p = 0.03), and SVF (β = 0.004, p = 0.009) scores. In middle-aged subjects, SF was also associated with increased SVF scores (β = 0.005, p = 0.011). Lastly, in men, SF levels were negatively associated with R2*, a surrogate marker of brain iron content, in both the left frontal inferior opercular area (r = -0.41, p = 0.005) and the right frontal inferior opercular area (r = -0.44, p = 0.002). Conclusions: SF is significantly and positively associated with cognition. In older people with low SF levels, iron supplementation may be a promising therapy to improve cognition.